Finally, topical treatment with calcipotriol decreases the frequency of IL-17A+ CD8+ cells in psoriatic lesions, which is interesting in light of the correlations between these cells and disease activity in psoriatic arthritis (82, 209). This evidence concerns the gene IL17A and psoriatic arthritis.